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INTRODUCTION: We describe an unusual durability of a Hancock II porcine bioprosthesis in tricuspid
position. Sustainability of bioprostheses is known to be limited especially in young patients.
PRESENTATION OF THE CASE: A 52-year old Caucasian woman with a history of multiple valve interven-
tions.Her clinical presentationof dyspnoea and lower limboedema led to thediagnosis of severe tricuspid
valve stenosis and right heart failure, and was managed by the replacement of the tricuspid bioprosthesis
by another bioprosthesis 30-years after the initial implantation.
DISCUSSION: Calciﬁcation is the leading cause of bioprosthesis structural deterioration. This
immune–induced phenomenon is more pronounced in young patients. Although several patient-related
and valve-related factors inﬂuence the durability of a xenograft, unknown factors may be of some impor-
tance.
CONCLUSION: To our knowledge, this is the ﬁrst report of a 30-year durability of tricuspid bioprosthesis
in a young recipient. In the absence of extensive calciﬁcations, pannus formation covering the whole
prosthesis, peculiar hemodynamics and other unknown factors might have contributed to an extended
durability in this young patient.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The Hancock II valve bioprosthesis (Hancock II; Medtronic, Inc
Minneapolis, Mn) was commercialized in1982. It is a porcine bio-
prosthesis ﬁxed at low pressure in glutaraldehyde (0.625%) to
preserve the natural collagen crimping, treated with a calcium-
retarding agent (T6 sodium dodecyl sulphate), and mounted on
a low-proﬁle Delrin stent (Dupont, Wilmington, Del) [1]. Excel-
lent long-term durability has been showed especially in the aortic
position [2].
2. Presentation of case
A 52-year Caucasian woman, operated for the ﬁrst time in 1965
for complete atrio-ventricular canal, underwent in 1983 mitral
and tricuspid valve replacement with Hancock II porcine biopros-
theses for advanced rheumatic valve disease. In 1988, the mitral
bioprosthesis was replaced by a St Jude mechanical valve because
of structural valve deterioration due to excessive calciﬁcation.
The patient did well for over 25 years, until the beginning of
2013 when she experienced shortness of breath and presented an
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important lower limb oedema. Patient’s dyspnoea progressed
to a NYHA functional class IV with development of right heart
failure, pleural effusions andascitis. Trans-thoracic (TTC) and trans-
oesophageal (TEE) echocardiography revealed severe deterioration
of the tricuspid bioprosthesis with a IV/IV regurgitation surpris-
ingly without any calciﬁcation of the free-moving leaﬂets. By
contrast, the papillary muscles were completely immobilized and
severely calciﬁed (Fig. 1), thus creatingakindof tunneldownstream
the valve with an important intra-ventricular pressure gradient.
The pre-operative coronary angiography was normal. At the fourth
reoperation in September 2013, the explanted prosthesis showed
holes and tears in all leaﬂets with no signs of calciﬁcation other
than at the level of the commissures. By contrast extensive pan-
nus proliferation surrounded the whole external clot surface even
covering the edges of the calciﬁed papillary muscles fused to the
leaﬂets at all three commissures with a severe creep stenosis of the
struts (Fig. 2). The calciﬁed papillary muscles were excised and the
tricuspid xenograft was replaced by another 31mm bioprosthe-
sis. Patient recovered uneventfully and remained asymptomatic at
1-year follow-up.
3. Discussion
Structural valve deterioration is the most common cause of
reoperation after bioprosthetic replacement and only few valves
remain functional beyond 20 years. Intrinsic calciﬁcation is the
http://dx.doi.org/10.1016/j.ijscr.2015.01.052
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Fig. 1. Echocardiography showing papillary muscle calciﬁcation.
Fig. 2. Holes and tears in the leaﬂet bioprosthesis, atrial and ventrical view.
leading cause of failure and reoperation as common in younger
patients and is more signiﬁcantly affected by this type of structural
valve deterioration [3]. Valfré and co-workers report an impressive
long-term durability of the Hancock bioprosthesis with a freedom
from re-operation in the aortic position of 79.3% and 52.8% in the
mitral at twenty years [4]. However few reports exists of a more
extended durability even in the tricuspid position [5]. Although
several patient-related and valve related factors may inﬂuence the
durability of a xenograft, the reasons for our unexpected longevity
are not easily explained. For thatmatter Butany and colleagues sug-
gested, that while pannus overgrowth usually is considered as a
cause of prosthetic dysfunction, it could be an important protec-
tive factor [6]. In our patient the pannus overgrowth was abundant
covering the whole stent but also the leaﬂets at the commis-
sures, possibly contributing to its protection from both increasing
mechanical stress and excessive calciﬁcation. Another observation
was the complete fusion of the papillary muscles with the struts
as often seen in rheumatic valve disease. In this particular case the
ﬁxation of the sub-valvular apparatus to the struts created a per-
fect tubular structure downstream the prosthesis inside the right
ventricle. It might have temporarily improved the hemodynamics
avoiding any turbulent ﬂow across the valve henceforth lowering
the stress on the leaﬂets. Those two observations might contribute
to this exceptional durability in addition to others unknown fac-
tors. However once the valve became truly stenotic due to the creep
stenosis our patient’s symptoms rapidly increased.
4. Conclusion
To our knowledge this is the ﬁrst report of a 30-year dura-
bility of a tricuspid bioprosthesis in a young recipient. Excessive
calciﬁcation, normally the leading cause of structural prosthetic
deterioration, was not observed in this case. Pannus formation cov-
ering thewhole stent of theprosthesis, peculiar hemodynamics and
others unknown factors might have contributed to the extended
durability in this young patient.
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